Potential theoretical benefits include: Body composition considerations : Tirzepatide promotes significant fat loss through appetite suppression and metabolic effects, while sermorelin might theoretically support lean muscle preservation through growth hormone stimulationpotentially mitigating the muscle loss sometimes observed with rapid weight reduction
Animal Studies: Some animal studies have suggested that GLP-1 agonists could potentially lead to negative outcomes, such as delayed fetal development or other issues
These can include acne, sleep apnea, reduced sperm count, or an increased risk of certain conditions like blood clots
The problem is that modern life delivers constant low-grade stressors work pressures, financial concerns, family responsibilities, and the physical stress of menopause itself that keep cortisol chronically elevated
Most stomach issues resolve on their own
Food and Drug Administration (FDA) and has no established safety dataquite the opposite, in fact